CVS.DE
Get informed when a big investor buys or sells
+ FollowUndervalued by 161.1% based on the discounted cash flow analysis.
| Market cap | $110.74 Billion |
|---|---|
| Enterprise Value | $175.72 Billion |
| Dividend Yield | $2.30 (3.09%) |
| Earnings per Share | $1.4 |
| Beta | 0.58 |
| Outstanding Shares | 1,279,000,000 |
| P/E Ratio | 22.5 |
|---|---|
| PEG | 11.64 |
| Price to Sales | 0.24 |
| Price to Book Ratio | 1.26 |
| Enterprise Value to Revenue | 0.42 |
| Enterprise Value to EBIT | 19.77 |
| Enterprise Value to Net Income | 35 |
| Total Debt to Enterprise | 0.43 |
| Debt to Equity | 0.96 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and O...